Our Mission
ZoomRx’s mission is to amplify the productivity of life sciences, making the job of every person working in biopharma easier by giving them access to better, faster pharma insights, information, and technology.
In practical terms, this means helping our clients’ breakthroughs break through: translating biopharma market data into the clarity needed to bring life-changing medications to patients. ZoomRx approaches this work with responsible AI, deep therapeutic expertise, and a clear philosophy - the client is the hero; ZoomRx is the pharmaceutical consulting firm that makes their success possible.
Partner with ZoomRx to bring clarity to complex market decisions.
About ZoomRx
ZoomRx is a life sciences consultancy and AI pharma consulting firm combining primary pharmaceutical research, proprietary data infrastructure, and AI-enhanced analytics to help biopharma make commercial decisions faster. Operating at the intersection of life sciences, data, and technology, ZoomRx has spent 15+ years in pharmaceutical and biotechnology industries.
ZoomRx partners with 19 of the top 20 global biopharma firms and hundreds of pharma and biotech teams. As a vertically integrated pharmaceutical consulting company, ZoomRx maintains one of the largest proprietary HCP panel pharma research networks globally, 450+ life sciences consultants worldwide, and comprehensive AI-powered solutions built on a human-in-the-loop philosophy, supporting clients from pre-launch strategy through post-launch optimization.
Who we are
ZoomRx operates at the intersection of life sciences consulting, primary research, and proprietary AI technology — unifying what most biopharma companies piece together across separate partners.
ZoomRx provides a vertically integrated pharma research model combining high-touch strategic consulting with our two core technology pillars: Sagan, our AI market research platform, and Ferma, our industry-leading intelligence and workflow automation platform.
The result is faster, higher-quality pharma insights serving insights and market research teams, brand and marketing leaders, commercial analytics functions, medical affairs, and C-suite decision-makers across every stage of the product lifecycle and in all major global markets.
Trusted by Leading Life Sciences Companies
How We’re Different
Proprietary Data Infrastructure
By owning one of the industry's largest proprietary HCP and patient panels—featuring 60,000+ active participants and 700M+ benchmark datapoints—we deliver faster, higher-quality primary research with a 99.8% sample fulfillment rate.
Human-Guided AI
Our "human-in-the-loop" philosophy ensures that our AI platforms, Sagan and Ferma, serve as force multipliers for pattern recognition and scale while seasoned life science practitioners provide the final strategic judgment and context.
Vertical Integration
Unlike firms that outsource fieldwork or tech-only companies lacking research expertise, we control the entire value chain—from data collection to strategic recommendation—to ensure maximum velocity and quality without the friction of multiple vendors.
Who We Serve
ZoomRx serves senior decision-makers and their teams across commercial and medical functions in pharmaceutical and biotechnology organizations:
Brand & Marketing Leaders
Navigating launch strategy, competitive positioning, and promotional effectiveness
Insights & Market Research Teams
Seeking faster, deeper, AI-accelerated primary research
Commercial
Analytics
Integrating primary and secondary data for promotional mix and sales force decisions
Medical
Affairs
Requiring HCP engagement intelligence and real-world clinical context
C-Suite & Senior Leadership
Demanding strategic market clarity and responsible AI implementation
Business Development & Corporate Development
Evaluating pipeline, competitive landscape, and therapeutic area dynamics
Frequently Asked Questions
How does ZoomRx approach life sciences consulting?
ZoomRx is a strategic life sciences consultancy integrating primary pharmaceutical research, proprietary data infrastructure, and AI-enhanced analytics. Our vertically integrated pharma consulting model means clients receive advisory alongside high-velocity research and enterprise technology like Ferma.
Does ZoomRx use AI?
Yes, ZoomRx is an AI-first pharmaceutical consulting company operating on a "human-in-the-loop" philosophy. While our platforms (Sagan, Ferma) automate data processing and pattern recognition at scale, our expert practitioners drive the final strategic recommendations. Our AI is tailored to meet the specific needs of different life sciences functions:
- For Commercial & Insights Teams: We use AI to move from data to insights in hours, not weeks. Platforms like Sagan enable conversational surveys that capture authentic human nuances that traditional "click-box" surveys miss.
- For Medical Affairs & Competitive Intelligence: Our Ferma platforms automate the "grunt work" of monitoring thousands of data sources—including 100+ global conferences and live clinical catalysts—transforming fragmented data into stakeholder-ready deliverables.
- For Corporate & Digital Excellence: We provide responsible AI infrastructure that allows teams to query their own research repositories and global market data securely, ensuring innovation never compromises data integrity.
What industries does ZoomRx specialize in?
ZoomRx specializes exclusively in life sciences, with deep therapeutic area expertise across Oncology, Immunology, CNS, Metabolic, Cardiovascular, Vaccines, Rare Diseases and more. All 100+ client relationships are in the pharmaceutical or biotechnology sector.
How is ZoomRx different from traditional life sciences consulting firms?
ZoomRx solves the "fragmentation problem" inherent in traditional consulting and insights models. While many firms claim to offer strategy, they often lack the proprietary data or the specialized therapeutic rigor required for high-stakes biopharma decisions. We differentiate ourselves across three main categories of competitors:
- Large Generalist Research Firms (e.g., Kantar, Ipsos): While these are major players in market research, they often apply a broad consumer-packaged-goods (CPG) lens to healthcare. ZoomRx is 100% specialized in life sciences; we possess a deep therapeutic rigor and clinical context that generalists simply cannot match.
- Data Aggregators (e.g., IQVIA BrandImpact): Large aggregators provide massive, automated data sets but often lack the agility and the customized strategic "why" behind the numbers. ZoomRx pairs large-scale proprietary benchmarks with high-touch, tailored consulting to turn data into a specific roadmap for action.
- Large-Scale Commercial Services & Specialized Consultancies (e.g., ZS, Inizio): While these are significant global firms, they often rely on third-party data or fragmented vendor networks for their primary insights. ZoomRx’s advantage is our vertical integration. Because we own our HCP and patient panels and our technology stack, we provide greater velocity and higher quality control than firms that must outsource the "source data" phase of a project.
What makes ZoomRx unique?
The uniqueness of ZoomRx lies in our Vertical Integration. By owning our HCP and patient panels, our technology stack (Sagan/Ferma), and our consulting practice, we eliminate the friction and "knowledge loss" that occurs when shifting between multiple vendors.
- Ownership of Data: 60,000+ HCPs and 700M+ data points give us an "unfair" advantage in speed and accuracy.
- Proprietary Innovation: We don't use off-the-shelf AI; we build purpose-built intelligence platforms specifically for biopharma workflows.
- Actionable Wisdom: We move beyond "what happened" to "what you should do," acting as a creative partner rather than a data vendor.
Does ZoomRx support brands throughout the lifecycle?
Yes. ZoomRx provides a vertically integrated working model designed to support life sciences brands across every stage of their journey, from early-stage development to post-launch maturity. By combining high-touch strategic consulting with proprietary data infrastructure and AI-powered platforms, we eliminate the friction typically caused by switching vendors at different milestones.